Event related potentials (ERP) are important clinical and research instruments in neuropsychiatry, particularly due to their strategic role for the investigation of brain function. These techniques are often underutilized in the evaluation of neurological and psychiatric disorders, but nevertheless they can be most useful and highly effective in the diagnostic workup of a wide range of neuropsychiatric disorders as well as in monitoring the course of the disorders and the prediction of treatment responses.
ERP are noninvasive instruments that directly reflect cortical neuronal activity. Cortical neuronal dysfunction plays a major role in variable neuropsychiatric disorders, and a change in cortical activity under medication might reflect treatment response and could be useful for monitoring drug effects.
ERP are the only methods with a sufficiently high time resolution for the analysis of the dynamic patterns of neuronal brain activity, e.g., synchronization and desynchronization, oscillations, coherence, gamma band activity, latency of event related activity, etc., which are crucial for a deeper understanding of functional (neurophysiological) correlates of cognitive, emotional and behavioral disturbances in neuropsychiatric patients.
Methodological advances have further improved and strengthened the position of ERP concerning research and clinical application. The usefulness and applicability of ERP in determining and monitoring clinico-pharmacological effects will be summarized mainly by focussing on the auditory evoked P300 and the N1/P2 component of auditory evoked potentials. Owing to important recent developments in the field of brain functional diagnostics the combination of neurophysiological techniques and functional magnetic resonance imaging (fMRI) will be included.
MitzdorfU.Properties of cortical generators of event-related potentials. Pharmacopsychiatry1994; 27(2): 49–51.
2.
DierksTFrolichLIhlRMaurerK.Event-related potentials and psychopharmacology: Cholinergic modulation of P300. Pharmacopsychiatry1994; 27(2): 72–74.
3.
MurphyDLPeripheral indices of central serotonin function in humans. Ann N Y Acad Sci1990; 600: 282–296.
4.
HegerlU.Event-related potentials in psychiatry: A new perspective. Pharmacopsychiatry1994; 27(2): 47–48.
5.
HegerlUGallinatJJuckelG.Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord2001; 62(1–2): 93–100.
6.
JuckelGCsepeVMolnarMHegerlUKarmosG.Intensity dependence of auditory evoked potentials in behaving cats. Electroencephalogr Clin Neurophysiol1996; 100(6): 527–537.
7.
JuckelGHegerlUMolnarMCsepeVKarmosG.Auditory evoked potentials reflect serotonergic neuronal activity: A study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology1999; 21(6): 710–716.
GallinatJBottlenderRJuckelGMunke-PuchnerAStotzGKussHJThe loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl)2000; 148(4): 404–411.
10.
NaatanenRPictonT.The N1 wave of the human electric and magnetic response to sound: A review and an analysis of the component structure. Psychophysiology1987; 24(4): 375–425.
11.
HegerlUGallinatJMrowinskiD.Intensity dependence of auditory evoked dipole source activity. Int J Psychophysiol1994; 17(1): 1–13.
12.
BrechmannABaumgartFScheichH.Sound-level-dependent representation of frequency modulations in human auditory cortex: A low-noise fMRI study. J Neurophysiol2002; 87(1): 423–433.
13.
MulertCJagerLProppSKarchSLeichtGPogarellOLoudness dependence of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI. Neuroimage2004; 22(suppl 1): TU356.
14.
MulertCJagerLProppSKarchSStormannSPogarellOSound level dependence of the primary auditory cortex: Simultaneous measurement with 61-channel EEG and fMRI. Neuroimage2005; 28(1): 49–58.
15.
AdliMRushAJMollerHJBauerM.Algorithms for optimizing the treatment of depression: Making the right decision at the right time. Pharmacopsychiatry2003; 36(suppl 3):S222–229.
16.
HegerlUJuckelG.Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: A new hypothesis. Biol Psychiatry1993; 33(3): 173–187.
17.
HegerlUJuckelG.Auditory evoked dipole source activity: Indicator of central serotonergic dysfunction in psychiatric patients?Pharmacopsychiatry1994; 27(2): 75–78.
18.
HegerlUJuckelGSchmidtLGRommelspacherH.Serotonergic ethanol effects and auditory evoked dipole activity in alcoholic and healthy subjects. Psychiatry Res1996; 63(1): 47–55.
19.
HegerlULipperheideKJuckelGSchmidtLGRommelspacherH.Antisocial tendencies and cortical sensory-evoked responses in alcoholism. Alcohol Clin Exp Res1995; 19(1): 31–36.
20.
AzmitiaECGannonPJThe primate serotonergic system: A review of human and animal studies and a report on Macaca fascicularis. Adv Neurol1986; 43: 407–468.
21.
LewisDACampbellMJFooteSLMorrisonJHThe monoaminergic innervation of primate neocortex. Hum Neurobiol1986; 5(3): 181–188.
22.
SchergMPictonTWSeparation and identification of event-related potential components by brain electric source analysis. Electroencephalogr Clin Neurophysiol Suppl1991; 42: 24–37.
BruneauNBarthelemyCRouxSJouveJLelordG.Auditory evoked potential modifications according to clinical and biochemical responsiveness to fenfluramine treatment in children with autistic behavior. Neuropsychobiology1989; 21(1): 48–52.
25.
RoonKISandorPSSchoonmanGGLamersFPSchoenenJFerrariMDAuditory evoked potentials in the assessment of central nervous system effects of antimigraine drugs. Cephalalgia1999; 19(10): 880–885.
26.
HegerlUBottlenderRGallinatJKussHJAckenheilMMollerHJThe serotonin syndrome scale: First results on validity. Eur Arch Psychiatry Clin Neurosci1998; 248(2): 96–103.
27.
HegerlUGallinatJMrowinskiD.Sensory cortical processing and the biological basis of personality. Biol Psychiatry1995; 37(7): 467–472.
28.
MulertCJuckelGAugustinHHegerlU.Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression. Clin Neurophysiol2002; 113(10): 1566–1572.
29.
HegerlUWulffHMuller-OerlinghausenB.Intensity dependence of auditory evoked potentials and clinical response to prophylactic lithium medication: A replication study. Psychiatry Res1992; 44(3): 181–190.
30.
HegerlUUlrichGMuller-OerlinghausenB.Auditory evoked potentials and response to lithium prophylaxis. Pharmacopsychiatry1987; 20(5): 213–216.
31.
HegerlUWulffHMuller-OerlinghausenB.Intensity dependence of auditory evoked potentials and clinical response to prophylactic lithium medication: A replication study. Psychiatry Res1992; 44(3): 181–190.
32.
PenhuneVBZatorreRJMacDonaldJDEvansACInterhemispheric anatomical differences in human primary auditory cortex: Probabilistic mapping and volume measurement from magnetic resonance scans. Cereb Cortex1996; 6(5): 661–672.
33.
MulertCGallinatJPascual-MarquiRDornHFrickKSchlattmannPReduced event-related current density in the anterior cingulate cortex in schizophrenia. Neuroimage2001; 13(4): 589–600.
34.
KolesZFlor-HenryPLindJ.Low-resolution electrical tomography of the brain during psychometrically matched verbal and spatial cognitive tasks. Hum Brain Mapp2001; 12(3): 144–156.
35.
LavricAPizzagalliDForstmeierSRipponG.A double-dissociation of English past-tense production revealed by event-related potentials and low-resolution electromagnetic tomography (LORETA). Clin Neurophysiol2001; 112(10): 1833–1849.
AndererPSaletuBSemlitschHVPascual-MarquiRDNon-invasive localization of P300 sources in normal aging and age-associated memory impairment. Neurobiol Aging2003; 24(3): 463–479.
38.
Pascual-MarquiRDMichelCMLehmannD.Low resolution electromagnetic tomography: A new method for localizing electrical activity in the brain. Int J Psychophysiol1994; 18(1): 49–65.
MulertCJagerLSchmittRBussfeldPPogarellOMollerHJIntegration of fMRI and simultaneous EEG: Towards a comprehensive understanding of localization and time-course of brain activity in target detection. Neuroimage2004; 22(1): 83–94.
41.
HartHCPalmerARHallDAHeschl's gyrus is more sensitive to tone level than non-primary auditory cortex. Hear Res2002; 171(1–2): 177–190.
42.
JanckeLShahNJPosseSGrosse-RyukenMMuller-GartnerHWIntensity coding of auditory stimuli: An fMRI study. Neuropsychologia1998; 36(9): 875–883.
43.
MorrisonJHFooteSLNoradrenergic and serotoninergic innervation of cortical, thalamic, and tectal visual structures in Old and New World monkeys. J Comp Neurol1986; 243(1): 117–138.
44.
PogarellOTatschKJuckelGHamannCMulertCPoppedGSerotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Neuropsychopharmacology2004; 29(10): 1910–1917.
45.
VerlegerR.Event related potentials and cognition: A critique of the context updating hypothesis and an alternative interpretation of P3. Behav Brain Sci1988; 11: 343–356.
46.
DonchinEColesM.Is the P300 component a manifestation of context updating?Behav Brain Sci1988. 1988; 11: 357–374.
47.
MolnarM.On the origin of the P3 event-related potential component. Int J Psychophysiol1994; 17(2): 129–144.
48.
Frodl-BauchTBottlenderRHegerlU.Neurochemical substrates and neuroanatomical generators of the event-related P300. Neuropsychobiology1999; 40(2): 86–94.
49.
HammondEJMeadorKJAung-DinRWilderBJCholinergic modulation of human P3 event-related potentials. Neurology1987; 37(2): 346–350.
50.
MeadorKJCholinergic, serotonergic, and GABAergic effects on the ERP. Electroencephalogr Clin Neurophysiol Suppl1995; 44: 151–155.
51.
MeadorKJLoringDWDavisHCSethiKDPatelBRAdamsRJCholinergic and serotonergic effects on the P3 potential and recent memory. J Clin Exp Neuropsychol1989; 11(2): 252–260.
52.
GoodinDSSquiresKCHendersonBHStarrA.Age-related variations in evoked potentials to auditory stimuli in normal human subjects. Electroencephalogr Clin Neurophysiol1978; 44(4): 447–458.
53.
PfefferbaumAFordJMKraemerHCClinical utility of long latency “cognitive” event-related potentials (P3): The cons. Electroencephalogr Clin Neurophysiol1990; 76(1): 6–12.
54.
PolichJLadishCBloomFEP300 assessment of early Alzheimer's disease. Electroencephalogr Clin Neurophysiol1990; 77(3): 179–189.
55.
ItoJYamaoSFukudaHMimoriYNakamuraS.The P300 event-related potentials in dementia of the Alzheimer type: Correlations between P300 and monoamine metabolites. Electroencephalogr Clin Neurophysiol1990; 77(3): 174–178.
56.
MaurerKDierksT.Functional imaging of the brain in psychiatry: Mapping of EEG and evoked potentials. Neurosurg Rev1987; 10(4): 275–282.
57.
HegerlUFrodl-BauchT.Dipole source analysis of P300 component of the auditory evoked potential: A methodological advance?Psychiatry Res1997; 74(2): 109–118.
58.
MulertCPogarellOJuckelGRujescuDGieglingIRuppDThe neural basis of the P300 potential: Focus on the time-course of the underlying cortical generators. Eur Arch Psychiatry Clin Neurosci2004; 254(3): 190–198.
59.
FrodlTHampelHJuckelGBurgerKPadbergFEngelRRValue of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's Disease. Psychophysiology2002; 39(2): 175–181.
60.
ThomasAIaconoDBonanniLD'AndreamatteoGOnofrjM.Donepezil, rivastigmine, and vitamin E in Alzheimer disease: A combined P300 event-related potentials/neuropsychologic evaluation over 6 months. Clin Neuropharmacol2001; 24(1): 31–42.
61.
OnofrjMThomasALucianoALIaconoDDi RolloAD'AndreamatteoGDonepezil versus vitamin E in Alzheimer's disease. II. Mild versus moderate-severe Alzheimer's disease. Clin Neuropharmacol2002; 25(4): 207–215.
62.
PogarellOSchulzCJuckelGMueller-SiechenederFLauxGBahraRAuditory evoked P300 and treatment response to donepezil in patients with Alzheimer's disease. World J Biol Psychiatry2001; 2: 264.
63.
HalgrenEMarinkovicKChauvelP.Generators of the late cognitive potentials in auditory and visual oddball tasks. Electroencephalogr Clin Neurophysiol1998; 106(2): 156–164.
64.
Pascual-MarquiRDReview of methods for solving the EEG inverse problem. Int J Bioelectromagnetism1999; 1(1): 75–86.
65.
McCarthyGLubyMGoreJGoldman-RakicP.Infrequent events transiently activate human prefrontal and parietal cortex as measured by functional MRI. J Neurophysiol1997; 77(3): 1630–1634.
66.
LindenDEPrvulovicDFormisanoEVollingerMZanellaFEGoebelRThe functional neuroanatomy of target detection: An fMRI study of visual and auditory oddball tasks. Cereb Cortex1999; 9(8): 815–823.
67.
KiehlKALaurensKRDutyTLForsterBBLiddlePFNeural sources involved in auditory target detection and novelty processing: An event-related fMRI study. Psychophysiology2001; 38(1): 133–142.
68.
KiehlKALiddlePFAn event-related functional magnetic resonance imaging study of an auditory oddball task in schizophrenia. Schizophr Res2001; 48(2–3): 159–171.
69.
IwanamiAKatoNKasaiKKamioSFurukawaSFukudaMP300 amplitude over temporal regions in schizophrenia. Eur Arch Psychiatry Clin Neurosci2002; 252(1): 1–7.
70.
GreenMFNuechterleinKHCortical oscillations and schizophrenia: Timing is of the essence [comment]. Arch Gen Psychiatry1999; 56(11): 1007–1008.
71.
GreenMFNuechterleinKHShould schizophrenia be treated as a neurocognitive disorder?Schizophr Bull1999; 25(2): 309–319.
72.
LogothetisNKPaulsJAugathMTrinathTOeltermannA.Neurophysiological investigation of the basis of the fMRI signal. Nature2001; 412(6843): 150–157.
73.
EngelAKFriesPSingerW.Dynamic predictions: Oscillations and synchrony in top-down processing. Nat Rev Neurosci2001; 2(10): 704–716.
74.
EngelAKSingerW.Temporal binding and the neural correlates of sensory awareness. Trends Cogn Sci2001; 5(1): 16–25.
